Reminders are published daily by the authorities. This time, one of them concerns drugs. The National Agency for the Safety of Medicines and Health Products (ANSM) has just recalled a batch of atorvastatin, a drug used in the treatment of long-term cholesterol.
A gliclazide tablet, indicated in the treatment of non-insulin-dependent type 2 diabetes, was found in the bottle, we can read in the recall published on the ANSM website. Both tablets are white in color but their shape and engraving are different. According to the Agency, this packaging error has only been reported for one bottle to date. It does not concern boxes of atorvastatin in blister packs. This is therefore a “precautionary” recall.
Risk of hypoglycemia
The batch of Atorvastatin Arrow Generics 10 mg (30 tablets) was distributed from 02/05/2024 in pharmacies and hospitals. The recalled lot is JBM2300810F. If another reference is written on the bottle you hold, you are not affected by this recall. “If the reference JBM2300810F is listed, do not stop or change your treatment without medical advice and return your bottle to the pharmacy,” indicates the ANSM. A compliant bottle will then be given to you.
The risk for patients taking gliclazide instead of atorvastatin is hypoglycemia. “If after taking your usual atorvastatin 10 mg treatment you experience symptoms suggestive of hypoglycemia such as sweating, paleness, abnormal feeling of hunger, nausea, tremors, dizziness, headache, dizziness, contact your doctor,” advises the ANSM.
France
Health
